HR Execs on the Move

Medical Informatics Engineering

www.mieweb.com

 
Founded in 1995, MIE has developed the WebChart EHR portfolio, a minimally invasive EHR which operates on any web browser or mobile device, including iPads or Smartphones.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.mieweb.com
  • 6302 Constitution Dr
    Fort Wayne, IN USA 46804
  • Phone: 260.459.6270

Executives

Name Title Contact Details

Similar Companies

Tactx Medical Produxx

Tactx Medical Produxx is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dynatronics

Dynatronics is a medical device company committed to providing high-quality restorative products designed to accelerate one to their optimal health. The company designs, manufactures, and sells a broad range of products for clinical use in physical therapy, rehabilitation, pain management, and athletic training. Through its distribution channels, Dynatronics markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and consumers. The company is headquartered in greater Salt Lake City, Utah, and its products are marketed under a portfolio of brands including Bird & Cronin®, Dynatron Solaris®, Hausmann, Physician`s Choice®, and PROTEAM™.

ZLB Plasma Services

ZLB Plasma Services is a Boca Raton, FL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

BAROnova

BAROnova, Inc., founded in 2006 and based in Goleta, CA, is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.

Reva Medical

Founded in 1998, REVA Medical is dedicated to developing minimally invasive medical devices that leverage its proprietary biomaterial and stent technologies to improve the treatment of coronary artery disease. Guided by an executive management team and scientific advisors with extensive product development and clinical interventional cardiology experience, REVA’s initial focus is the development of a drug-eluting bioresorbable coronary scaffold to advance the treatment of cardiovascular disease, the leading cause of death worldwide.